AMPK: Lessons from transgenic and knockout animals.
暂无分享,去创建一个
Louise Lantier | Christophe Beauloye | B. Viollet | L. Bertrand | M. Foretz | F. Andreelli | Elham Zarrinpashneh | C. Beauloye | S. Horman | R. Ventura-clapier | R. Mounier | Benoit Viollet | L. Lantier | B. Guigas | Bruno Guigas | Marc Foretz | Luc Bertrand | S. Hébrard | Sandrine Horman | Fabrizio Andreelli | Yoni Athea | Remi Mounier | Elham Zarrinpashneh | Sophie Hebrard | Jocelyne Devin-Leclerc | Renee Ventura-Clapier | Yoni Athéa | J. Devin-Leclerc | Yoni Athéa | Christophe Beauloye
[1] C. C. Hale,et al. Metabolic activation of AMP kinase in vascular smooth muscle. , 2005, Journal of applied physiology.
[2] R. Heath,et al. Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family* , 2007, Journal of Biological Chemistry.
[3] Ki-Up Lee,et al. Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis , 2005, Journal of Molecular Medicine.
[4] B. Viollet,et al. Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver , 2006, Molecular Pharmacology.
[5] B. Spiegelman,et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α , 2007, Proceedings of the National Academy of Sciences.
[6] D. Hardie,et al. Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase* , 2005, Journal of Biological Chemistry.
[7] Peter Schjerling,et al. Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle* , 2004, Journal of Biological Chemistry.
[8] J. Balschi,et al. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. , 2007, American journal of physiology. Heart and circulatory physiology.
[9] M. J. Vazquez,et al. Central administration of resistin promotes short-term satiety in rats. , 2005, European journal of endocrinology.
[10] Michael D. Schneider,et al. A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway , 2006, Proceedings of the National Academy of Sciences.
[11] G. Ronnett,et al. Developing a head for energy sensing: AMP‐activated protein kinase as a multifunctional metabolic sensor in the brain , 2006, The Journal of physiology.
[12] J. Seidman,et al. AMP-Activated Protein Kinase in the Heart: Role During Health and Disease , 2007, Circulation research.
[13] P. Neufer,et al. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] W. G. Wiles,et al. Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo , 2004, Journal of Biological Chemistry.
[15] B. Viollet,et al. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases]. , 2006, Medecine sciences : M/S.
[16] P. Froguel,et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.
[17] B. Viollet,et al. AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.
[18] L. Bertrand,et al. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. , 2002, European journal of biochemistry.
[19] J. Wojtaszewski,et al. AS160 phosphorylation is associated with activation of α2β2γ1- but not α2β2γ3-AMPK trimeric complex in skeletal muscle during exercise in humans , 2007 .
[20] L. Bertrand,et al. Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. , 2002, Journal of molecular and cellular cardiology.
[21] Ferhaan Ahmad,et al. A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. , 2007, Biochemical and biophysical research communications.
[22] S. Gordon,et al. Impaired overload‐induced muscle growth is associated with diminished translational signalling in aged rat fast‐twitch skeletal muscle , 2006, The Journal of physiology.
[23] L. Bertrand,et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. , 2006, American journal of physiology. Heart and circulatory physiology.
[24] J. Seidman,et al. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. , 2007, The Journal of clinical investigation.
[25] S. Gordon,et al. Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation. , 2005, Journal of applied physiology.
[26] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[27] P. Saha,et al. Increased β-Oxidation but No Insulin Resistance or Glucose Intolerance in Mice Lacking Adiponectin* , 2002, The Journal of Biological Chemistry.
[28] M. Steinmetz,et al. Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5'AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. , 2004, European journal of biochemistry.
[29] B. Kemp,et al. Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. , 2007, American journal of physiology. Endocrinology and metabolism.
[30] D. Hardie,et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.
[31] Roy J Martin,et al. Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. , 2005, Endocrinology.
[32] C. Kahn,et al. Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3 , 2006, Molecular and Cellular Biology.
[33] P. Lawrence,et al. Genes in development , 1977, Nature.
[34] D. Hardie,et al. AMP-activated protein kinase as a drug target. , 2007, Annual review of pharmacology and toxicology.
[35] B. Viollet,et al. AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. , 2007, Diabetes.
[36] P. Ortiz de Montellano,et al. AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.
[37] M. Lane,et al. The Role of Hypothalamic Malonyl-CoA in Energy Homeostasis* , 2006, Journal of Biological Chemistry.
[38] A. Ashworth,et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. , 2006, American journal of physiology. Endocrinology and metabolism.
[39] B. Viollet,et al. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. , 2006, Diabetes.
[40] B. Viollet,et al. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. , 2006, Endocrinology.
[41] D. Bolster,et al. AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling* , 2002, The Journal of Biological Chemistry.
[42] J. Olefsky,et al. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. , 2004, The Journal of clinical investigation.
[43] L. Witters,et al. The effects of AICAR on adipocyte differentiation of 3T3-L1 cells. , 2001, Biochemical and biophysical research communications.
[44] B. Viollet,et al. AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. , 2007, The Biochemical journal.
[45] L. McCullough,et al. Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke* , 2005, Journal of Biological Chemistry.
[46] D. Hardie,et al. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. , 1996, The American journal of physiology.
[47] S. Gygi,et al. An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegans , 2007, Current Biology.
[48] P. Distefano,et al. Aging networks in Caenorhabditis elegans: AMP‐activated protein kinase (aak‐2) links multiple aging and metabolism pathways , 2006, Aging cell.
[49] B. Viollet,et al. Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.
[50] L. Rossetti,et al. Molecular disruption of hypothalamic nutrient sensing induces obesity , 2006, Nature Neuroscience.
[51] G. Shulman,et al. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. , 2001, American journal of physiology. Endocrinology and metabolism.
[52] B. Viollet,et al. Activation of AMP‐activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders , 2006, The Journal of physiology.
[53] M. Birnbaum,et al. Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. , 2001, Biochemical Society transactions.
[54] D. Befroy,et al. Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis , 2007, Cell metabolism.
[55] I. Tabata,et al. Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. , 2002, Biochemical and biophysical research communications.
[56] J. Zierath,et al. 5′‐AMP‐activated protein kinase regulates skeletal muscle glycogen content and ergogenics , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] Jun Hee Lee,et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase , 2007, Nature.
[58] D. St Johnston,et al. LKB1 and AMPK maintain epithelial cell polarity under energetic stress , 2007, The Journal of cell biology.
[59] T. Shimokawa,et al. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[60] B. Viollet,et al. Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. , 2006, American journal of physiology. Heart and circulatory physiology.
[61] R. Coleman,et al. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. , 1999 .
[62] D. Hardie,et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.
[63] M. Bohlooly-y,et al. Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.
[64] Kei Sakamoto,et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction , 2005, The EMBO journal.
[65] G. Lopaschuk,et al. AMPK alterations in cardiac physiology and pathology: enemy or ally? , 2006, The Journal of physiology.
[66] Jean Girard,et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. , 2005, The Journal of clinical investigation.
[67] D. Carling,et al. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinase , 1994, FEBS letters.
[68] B. Kemp,et al. Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. , 2001 .
[69] J. Apfeld,et al. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. , 2004, Genes & development.
[70] B. Viollet,et al. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. , 2007, American journal of physiology. Heart and circulatory physiology.
[71] Rene,et al. THE AMERICAN JOURNAL OF PHYSIOLOGY. , 1897, Science.
[72] D. Grahame Hardie,et al. Possible involvement of AMP‐activated protein kinase in obesity resistance induced by respiratory uncoupling in white fat , 2004, FEBS letters.
[73] R. Russell,et al. AMP-activated protein kinase: a key stress signaling pathway in the heart. , 2005, Trends in cardiovascular medicine.
[74] O. Ljungqvist,et al. Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. , 2000, Biochemical and biophysical research communications.
[75] Russell G. Jones,et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.
[76] D. Vertommen,et al. New targets of AMP-activated protein kinase. , 2001, Biochemical Society transactions.
[77] F. Dela,et al. 5′AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes , 2005, The Journal of physiology.
[78] B. Kemp,et al. Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.
[79] E. D. Muse,et al. Hypothalamic resistin induces hepatic insulin resistance. , 2007, The Journal of clinical investigation.
[80] R. Palanivel,et al. Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin , 2005, FEBS letters.
[81] N. Fujii,et al. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation. , 2006, American journal of physiology. Endocrinology and metabolism.
[82] B. Viollet,et al. Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. , 2004, Diabetes.
[83] R. DePinho,et al. The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.
[84] P. Neufer,et al. Effects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscle , 2005 .
[85] B. Viollet,et al. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. , 2007, The Journal of physiology.
[86] P. Bénit,et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. , 2007, Cell metabolism.
[87] G. Ronnett,et al. C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase* , 2004, Journal of Biological Chemistry.
[88] M. Raney,et al. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction. , 2005, American journal of physiology. Endocrinology and metabolism.
[89] J. Schneider,et al. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2006, American journal of physiology. Heart and circulatory physiology.
[90] Roberto Conti,et al. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.
[91] Kohjiro Ueki,et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.
[92] W. Winder,et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. , 2000, Journal of applied physiology.
[93] G. Hjälm,et al. The 5′-AMP-activated Protein Kinase γ3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle* , 2004, Journal of Biological Chemistry.
[94] R. Tian,et al. AMP‐activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP‐sensitive K+ channels , 2007, Journal of cellular physiology.
[95] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[96] N. Fujii,et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. , 2003, The Journal of biological chemistry.
[97] G. Shulman,et al. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. , 2001, Diabetes.
[98] M. Raney,et al. Regulation of contraction-induced FA uptake and oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle. , 2006, American journal of physiology. Endocrinology and metabolism.
[99] O. Pedersen,et al. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. , 2002, Diabetes.
[100] P. Puigserver,et al. Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.
[101] J. Connell,et al. Direct Activation of AMP-activated Protein Kinase Stimulates Nitric-oxide Synthesis in Human Aortic Endothelial Cells* , 2003, Journal of Biological Chemistry.
[102] M. Bucan,et al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.
[103] C. Bruce,et al. AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle , 2005, The Journal of physiology.
[104] L. Rossetti,et al. Hypothalamic sensing of fatty acids , 2005, Nature Neuroscience.
[105] N. Kimura,et al. A possible linkage between AMP‐activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[106] G. Barsh,et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. , 2007, The Journal of clinical investigation.
[107] D. Carling,et al. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. , 2000, The Biochemical journal.
[108] N. Fujii,et al. Skeletal Muscle Adaptation to Exercise Training , 2007, Diabetes.
[109] Margaret S. Wu,et al. Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.
[110] M. Birnbaum,et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.
[111] G. Kobinger,et al. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. , 2003, American journal of physiology. Cell physiology.
[112] R. Roy,et al. Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling , 2006, Development.
[113] S. Woods,et al. Central nervous system control of food intake , 2000, Nature.
[114] D. Hardie,et al. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.
[115] D. Carling,et al. AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.
[116] D. Carling,et al. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. , 2007, The Biochemical journal.
[117] N. Fujii,et al. Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle -insight from analysis of a transgenic mouse model-. , 2007, Diabetes research and clinical practice.
[118] G. Taffet,et al. Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome , 2005, Circulation.
[119] D. Vertommen,et al. Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis , 2002, Current Biology.
[120] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[121] David Carling,et al. Thr2446 Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status* , 2004, Journal of Biological Chemistry.
[122] Philippe Froguel,et al. Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.
[123] Kohjiro Ueki,et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. , 2007, Cell metabolism.
[124] N. Fujii,et al. AMP-activated Protein Kinase α2 Activity Is Not Essential for Contraction- and Hyperosmolarity-induced Glucose Transport in Skeletal Muscle* , 2005, Journal of Biological Chemistry.
[125] B. Viollet,et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. , 2006, Diabetes.
[126] K. Athenstaedt,et al. The neurodegeneration mutant löchrig interferes with cholesterol homeostasis and Appl processing , 2002, The EMBO journal.
[127] J. Wojtaszewski,et al. AS160 phosphorylation is associated with activation of alpha2beta2gamma1- but not alpha2beta2gamma3-AMPK trimeric complex in skeletal muscle during exercise in humans. , 2007, American journal of physiology. Endocrinology and metabolism.
[128] D. Fayuk,et al. The Journal of Physiology , 1978, Medical History.
[129] B. Viollet,et al. Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice , 2007 .
[130] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[131] G. Weigel,et al. Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres , 2006, Journal of Cell Science.
[132] D. Hardie,et al. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. , 2002, American journal of physiology. Endocrinology and metabolism.
[133] B. Viollet,et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. , 2005, Diabetes.
[134] D. Hardie,et al. 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.
[135] S. Gygi,et al. The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.
[136] P. Flachs,et al. Expression of the uncoupling protein 1 from the aP2 gene promoter stimulates mitochondrial biogenesis in unilocular adipocytes in vivo. , 2002, European journal of biochemistry.
[137] M. Birnbaum,et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.
[138] B. Viollet,et al. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. , 2004, The Journal of biological chemistry.
[139] J. Ninomiya-Tsuji,et al. AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart , 2005, Circulation research.
[140] H. Pilegaard,et al. Higher skeletal muscle α2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise , 2006, The Journal of physiology.
[141] B. Viollet,et al. Anti-lipolytic Action of AMP-activated Protein Kinase in Rodent Adipocytes* , 2005, Journal of Biological Chemistry.
[142] L. Kifle,et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. , 2006, Cell metabolism.
[143] N. Fujii,et al. Glucose Metabolism and Energy Homeostasis in Mouse Hearts Overexpressing Dominant Negative α2 Subunit of AMP-activated Protein Kinase* , 2003, Journal of Biological Chemistry.
[144] S. Uchida,et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.
[145] N. Fujii,et al. Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle , 2006, Diabetes.
[146] J. Wojtaszewski,et al. Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle , 2006, The Journal of physiology.
[147] S. Hawley,et al. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.
[148] Young-Bum Kim,et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.
[149] B. Viollet,et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. , 2003, The Journal of clinical investigation.
[150] B. Viollet,et al. Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. , 2007, American journal of physiology. Endocrinology and metabolism.
[151] Uwe Riek,et al. Dissecting the Role of 5′-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase* , 2006, Journal of Biological Chemistry.
[152] B. Viollet,et al. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase , 2004, Nature Medicine.
[153] Ferhaan Ahmad,et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.
[154] M. W. Schwartz,et al. Central nervous system control of food intake and body weight , 2006, Nature.
[155] G. Shulman,et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[156] B. Viollet,et al. The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. , 2004, Diabetes.
[157] George Thomas,et al. Hypothalamic mTOR Signaling Regulates Food Intake , 2006, Science.
[158] D. Hardie,et al. AMPK: a key sensor of fuel and energy status in skeletal muscle. , 2006, Physiology.
[159] C. Wyatt,et al. Does AMP-activated Protein Kinase Couple Inhibition of Mitochondrial Oxidative Phosphorylation by Hypoxia to Calcium Signaling in O2-sensing Cells?* , 2005, Journal of Biological Chemistry.
[160] B. Xue,et al. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues , 2006, The Journal of physiology.
[161] Anita Y. M. Chan,et al. Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.
[162] M. Birnbaum,et al. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.